Efficacy of second-line treatments for patients with advanced human epidermal growth factor receptor 2 positive breast cancer after trastuzumab-based treatment: a systematic review and bayesian network analysis

Purpose: Different second-line treatments of patients with trastuzumab-resistant human epidermal growth factor receptor 2 (HER2) positive breast cancer were examined in randomized controlled trials (RCTs). A network meta-analysis is helpful to evaluate the comparative survival benefits of different...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fei, Chen, Naifei, Lv, Zheng, Li, Lingyu, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890320/
https://www.ncbi.nlm.nih.gov/pubmed/33613756
http://dx.doi.org/10.7150/jca.51845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890320/
https://www.ncbi.nlm.nih.gov/pubmed/33613756
http://dx.doi.org/10.7150/jca.51845

Ejemplares similares